Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. (Record no. 4560)

MARC details
000 -LEADER
fixed length control field 03551nam a22003617a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 190827s20192019 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0028-4793
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1056/NEJMoa1807365 [doi]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 31433921
245 ## - TITLE STATEMENT
Title Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.
251 ## - Source
Source New England Journal of Medicine. 381(8):739-748, 2019 08 22.
252 ## - Abbreviated Source
Abbreviated source N Engl J Med. 381(8):739-748, 2019 08 22.
253 ## - Journal Name
Journal name The New England journal of medicine
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2019
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2020
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status ppublish
266 ## - Date added to catalog
Date added to catalog 2019-08-27
520 ## - SUMMARY, ETC.
Abstract BACKGROUND: The role of assessment of myocardial viability in identifying patients with ischemic cardiomyopathy who might benefit from surgical revascularization remains controversial. Furthermore, although improvement in left ventricular function is one of the goals of revascularization, its relationship to subsequent outcomes is unclear.
520 ## - SUMMARY, ETC.
Abstract CONCLUSIONS: The findings of this study do not support the concept that myocardial viability is associated with a long-term benefit of CABG in patients with ischemic cardiomyopathy. The presence of viable myocardium was associated with improvement in left ventricular systolic function, irrespective of treatment, but such improvement was not related to long-term survival. (Funded by the National Institutes of Health; STICH ClinicalTrials.gov number, NCT00023595.).
520 ## - SUMMARY, ETC.
Abstract Copyright (c) 2019 Massachusetts Medical Society.
520 ## - SUMMARY, ETC.
Abstract METHODS: Among 601 patients who had coronary artery disease that was amenable to coronary-artery bypass grafting (CABG) and who had a left ventricular ejection fraction of 35% or lower, we prospectively assessed myocardial viability using single-photon-emission computed tomography, dobutamine echocardiography, or both. Patients were randomly assigned to undergo CABG and receive medical therapy or to receive medical therapy alone. Left ventricular ejection fraction was measured at baseline and after 4 months of follow-up in 318 patients. The primary end point was death from any cause. The median duration of follow-up was 10.4 years.
520 ## - SUMMARY, ETC.
Abstract RESULTS: CABG plus medical therapy was associated with a lower incidence of death from any cause than medical therapy alone (182 deaths among 298 patients in the CABG group vs. 209 deaths among 303 patients in the medical-therapy group; adjusted hazard ratio, 0.73; 95% confidence interval, 0.60 to 0.90). However, no significant interaction was observed between the presence or absence of myocardial viability and the beneficial effect of CABG plus medical therapy over medical therapy alone (P = 0.34 for interaction). An increase in left ventricular ejection fraction was observed only among patients with myocardial viability, irrespective of treatment assignment. There was no association between changes in left ventricular ejection fraction and subsequent death.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element IN PROCESS -- NOT YET INDEXED
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Heart & Vascular Institute
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
657 ## - INDEX TERM--FUNCTION
Medline publication type Research Support, N.I.H., Extramural
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Asch, Federico M
790 ## - Authors
All authors Al-Khalidi HR, Asch FM, Berman DS, Bonow RO, Chrzanowski L, Ellis AM, Farsky PS, Favaloro LE, Holly TA, Kukulski T, Lee KL, Mark DB, Maurer G, Oh JK, Panza JA, Pohost GM, Rouleau JL, Sopko G, Tan RS, Velazquez EJ
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1056/NEJMoa1807365">https://dx.doi.org/10.1056/NEJMoa1807365</a>
Public note https://dx.doi.org/10.1056/NEJMoa1807365
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 08/27/2019   31433921 31433921 08/27/2019 08/27/2019 Journal Article

Powered by Koha